Header Logo

Connection

ALAN SWANN to Rats

Back to Details
This is a "connection" page, showing publications ALAN SWANN has written about Rats.
ALAN SWANN
Connection Strength
0.522
Rats
  1. Does a rat's exposure to cocaine during adolescence affect its response to cocaine in adulthood? Int J Neurosci. 2009; 119(6):879-907.
    View in: PubMed
    Score: 0.045
  2. Chronic treatment with valproate decreases the hypothermic response to clonidine. Pharmacol Biochem Behav. 1993 May; 45(1):247-9.
    View in: PubMed
    Score: 0.015
  3. Noradrenergic receptor mechanisms in neophobia. Psychopharmacology (Berl). 1992; 106(1):136-42.
    View in: PubMed
    Score: 0.014
  4. Brain Na+,K(+)-ATPase regulation in vivo: reduction in activity and response to sodium by intracerebroventricular tetrodotoxin. Brain Res. 1991 Mar 15; 543(2):251-5.
    View in: PubMed
    Score: 0.013
  5. Ethanol and (Na+,K+)-ATPase: alteration of Na(+)-K+ selectivity. Alcohol Clin Exp Res. 1990 Dec; 14(6):922-7.
    View in: PubMed
    Score: 0.013
  6. Repetitive methylphenidate administration modulates the diurnal behavioral activity pattern of adult female SD rats. J Neural Transm (Vienna). 2011 Feb; 118(2):285-98.
    View in: PubMed
    Score: 0.013
  7. Ethanol inhibition of active 86Rb(+)-transport: evidence for enhancement by sodium or calcium influx. J Pharmacol Exp Ther. 1990 Sep; 254(3):864-71.
    View in: PubMed
    Score: 0.013
  8. Nucleus accumbens lesions modulate the effects of methylphenidate. Brain Res Bull. 2010 Jul 30; 82(5-6):293-301.
    View in: PubMed
    Score: 0.012
  9. Psychostimulants given in adolescence modulate their effects in adulthood using the open field and the wheel-running assays. Brain Res Bull. 2010 May 31; 82(3-4):208-17.
    View in: PubMed
    Score: 0.012
  10. Inhibition of (Na+, K+)-ATPase by fluoride: evidence for a membrane adaptation to ethanol. Alcohol. 1990 Mar-Apr; 7(2):91-5.
    View in: PubMed
    Score: 0.012
  11. Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate. Brain Res. 2010 Feb 02; 1312:89-100.
    View in: PubMed
    Score: 0.012
  12. Noradrenaline and thyroid function regulate (Na+,K+)-adenosine triphosphatase independently in vivo. Eur J Pharmacol. 1989 Oct 10; 169(2-3):275-83.
    View in: PubMed
    Score: 0.012
  13. Forebrain norepinephrine involvement in selective attention and neophobia. Physiol Behav. 1989 Oct; 46(4):577-83.
    View in: PubMed
    Score: 0.012
  14. MDMA (ecstasy) modulates locomotor and prefrontal cortex sensory evoked activity. Brain Res. 2009 Dec 11; 1302:175-82.
    View in: PubMed
    Score: 0.012
  15. Descending glutamatergic pathways of PFC are involved in acute and chronic action of methylphenidate. Brain Res. 2009 Dec 08; 1301:68-79.
    View in: PubMed
    Score: 0.012
  16. Psychostimulant treatment for ADHD is modulated by prefrontal cortex manipulation. Brain Res Bull. 2009 Dec 16; 80(6):353-8.
    View in: PubMed
    Score: 0.012
  17. Does repetitive Ritalin injection produce long-term effects on SD female adolescent rats? Neuropharmacology. 2009 Sep; 57(3):201-7.
    View in: PubMed
    Score: 0.012
  18. Subacute noradrenergic agonist infusions in vivo increase Na+, K+-ATPase and ouabain binding in rat cerebral cortex. J Neurochem. 1989 May; 52(5):1598-604.
    View in: PubMed
    Score: 0.011
  19. Forskolin infusion in vivo increases ouabain binding in brain. Brain Res. 1989 Jan 09; 476(2):351-3.
    View in: PubMed
    Score: 0.011
  20. Adolescent and adult male spontaneous hyperactive rats (SHR) respond differently to acute and chronic methylphenidate (Ritalin). Int J Neurosci. 2009; 119(1):40-58.
    View in: PubMed
    Score: 0.011
  21. Dexamethasone and adrenalectomy alter brain (Na+,K+)-ATPase responses to noradrenergic stimulation or depletion. Eur J Pharmacol. 1988 Dec 06; 158(1-2):43-52.
    View in: PubMed
    Score: 0.011
  22. Prolonged methylphenidate treatment alters the behavioral diurnal activity pattern of adult male Sprague-Dawley rats. Pharmacol Biochem Behav. 2009 Mar; 92(1):93-9.
    View in: PubMed
    Score: 0.011
  23. Hemicholinium-3 binding: correlation with high-affinity choline uptake during changes in cholinergic activity. Neuropharmacology. 1988 Jun; 27(6):611-5.
    View in: PubMed
    Score: 0.011
  24. Norepinephrine and (Na+, K+)-ATPase: evidence for stabilization by lithium or imipramine. Neuropharmacology. 1988 Mar; 27(3):261-7.
    View in: PubMed
    Score: 0.011
  25. Methylphenidate sensitization is prevented by prefrontal cortex lesion. Brain Res Bull. 2008 May 15; 76(1-2):131-40.
    View in: PubMed
    Score: 0.010
  26. Thyroid hormone and norepinephrine: effects on alpha-2, beta, and reuptake sites in cerebral cortex and heart. J Neural Transm. 1988; 71(3):195-205.
    View in: PubMed
    Score: 0.010
  27. Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization. Brain Res. 2007 May 11; 1145:66-80.
    View in: PubMed
    Score: 0.010
  28. Acute and chronic methylphenidate dose-response assessment on three adolescent male rat strains. Brain Res Bull. 2006 Dec 11; 71(1-3):301-10.
    View in: PubMed
    Score: 0.010
  29. Chronic methylphenidate modulates locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats. Neuropharmacology. 2006 Sep; 51(3):546-56.
    View in: PubMed
    Score: 0.009
  30. Sensory-evoked potentials recordings from the ventral tegmental area, nucleus accumbens, prefrontal cortex, and caudate nucleus and locomotor activity are modulated in dose-response characteristics by methylphenidate. Brain Res. 2006 Feb 16; 1073-1074:164-74.
    View in: PubMed
    Score: 0.009
  31. Sex differences in tail-flick latency of non-stressed and stressed rats. Int J Neurosci. 2005 Oct; 115(10):1383-95.
    View in: PubMed
    Score: 0.009
  32. Differential locomotor responses in male rats from three strains to acute methylphenidate. Int J Neurosci. 2004 Sep; 114(9):1063-84.
    View in: PubMed
    Score: 0.008
  33. Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine. Life Sci. 2003 Oct 17; 73(22):2899-911.
    View in: PubMed
    Score: 0.008
  34. Strain differences in the behavioral responses of male rats to chronically administered methylphenidate. Brain Res. 2003 May 09; 971(2):139-52.
    View in: PubMed
    Score: 0.008
  35. Disruption of sensitization to methylphenidate by a single administration of MK-801. Life Sci. 2002 Mar 29; 70(19):2271-85.
    View in: PubMed
    Score: 0.007
  36. Methylphenidate sensitization is modulated by valproate. Life Sci. 2001 May 25; 69(1):47-57.
    View in: PubMed
    Score: 0.007
  37. Blockade of sensitization to methylphenidate by MK-801: partial dissociation from motor effects. Neuropharmacology. 2001; 40(2):298-309.
    View in: PubMed
    Score: 0.006
  38. Valproate prevents the induction of sensitization to methylphenidate (ritalin) in rats. Brain Res. 2000 Dec 29; 887(2):276-84.
    View in: PubMed
    Score: 0.006
  39. NMDA receptor antagonist disrupts acute and chronic effects of methylphenidate. Physiol Behav. 2000 Oct 1-15; 71(1-2):133-45.
    View in: PubMed
    Score: 0.006
  40. Valproate modulates the expression of methylphenidate (ritalin) sensitization. Brain Res. 2000 Aug 25; 874(2):216-20.
    View in: PubMed
    Score: 0.006
  41. Diurnal differences in sensitization to methylphenidate. Brain Res. 2000 May 02; 864(1):24-39.
    View in: PubMed
    Score: 0.006
  42. MK-801 blocks the development of sensitization to the locomotor effects of methylphenidate. Brain Res Bull. 2000 Apr; 51(6):485-92.
    View in: PubMed
    Score: 0.006
  43. Diurnal differences in amphetamine sensitization. Eur J Pharmacol. 1999 Jun 11; 374(1):1-9.
    View in: PubMed
    Score: 0.006
  44. Dose-related effects of MK-801 on acute and chronic methylphenidate administration. Brain Res. 1998 Dec 14; 814(1-2):78-85.
    View in: PubMed
    Score: 0.006
  45. Diurnal differences in rat's motor response to amphetamine. Eur J Pharmacol. 1998 Mar 19; 345(2):119-28.
    View in: PubMed
    Score: 0.005
  46. Time-dependent differences in the rat's motor response to amphetamine. Pharmacol Biochem Behav. 1998 Feb; 59(2):459-67.
    View in: PubMed
    Score: 0.005
  47. Methylphenidate: diurnal effects on locomotor and stereotypic behavior in the rat. Brain Res. 1997 Nov 28; 777(1-2):1-12.
    View in: PubMed
    Score: 0.005
  48. Behavioral sensitization to cocaine in the absence of altered brain cocaine levels. Pharmacol Biochem Behav. 1997 Aug; 57(4):665-9.
    View in: PubMed
    Score: 0.005
  49. Context-dependent cross-sensitization between cocaine and amphetamine. Life Sci. 1997; 60(1):PL1-7.
    View in: PubMed
    Score: 0.005
  50. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci. 1997; 61(8):PL101-7.
    View in: PubMed
    Score: 0.005
  51. Preliminary physiologically based pharmacokinetic model for cocaine in the rat: model development and scale-up to humans. J Pharm Sci. 1996 Aug; 85(8):878-83.
    View in: PubMed
    Score: 0.005
  52. Dose response characteristics of methylphenidate on different indices of rats' locomotor activity at the beginning of the dark cycle. Brain Res. 1996 Jul 15; 727(1-2):13-21.
    View in: PubMed
    Score: 0.005
  53. Effects of amphetamine at the beginning of the light cycle on multiple indices of motor activity in the rat. Eur J Pharmacol. 1996 Apr 04; 300(1-2):1-8.
    View in: PubMed
    Score: 0.005
  54. Development of ethanol tolerance not altered by 6-OHDA lesions of dorsal bundle. Pharmacol Biochem Behav. 1989 Jul; 33(3):729-31.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.